Caxton Associates (New York)’s Adaptive Biotechnologies ADPT Stock Holding History

Caxton Associates (New York)’s Portfolio ADPT Stock Details ADPT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$739K	Buy
2022 Q2	–	Sell
2022 Q1	$426K	Buy